Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Video
Understanding the Role of the COVID-19 Pandemic in Increased Substance Use Disorder: Opportunities for Pharmacist Intervention
An expert panel led by moderator Dr. Cunningham identify substance use disorder, COVID-19’s role, and opportunities for pharmacists to help patients with resources for recovery.
Please see PDF above for article related to this video.
Video Player is loading.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Videos
Future Considerations for the Management of Hyperlipidemia
Addressing Critical Gaps in the Management of NSCLC and the Importance of the Next Wave of Treatment Advances
Additional Considerations for LDL-C–Lowering Therapies
Monitoring Patients for Adverse Events and Optimizing Access to Therapies
Personalized Care: How Do NSCLC Treatment Modifications and Patient-Specific Factors Impact Health Outcomes?
Streamlining the Route of Administration of Monoclonal Antibody Therapies for Better Patient Outcomes in the NSCLC Population
Patient Education for LDL-C–Lowering Therapies
Identifying Nonadherence in Patients With Hyperlipidemia
Infusion Hesitancy and the Impact of Route of Administration of NSCLC Treatment Options in Patients’ Quality of Life
Infusion-Related Reactions: Clinical Trials and Guideline-Driven Prophylaxis and Management Strategies for Patients Undergoing NSCLC Treatment
Related Content
